Baytril^® Otic (enrofloxacin/silver sulfadiazine) Antibacterial-Antimycotic Emulsion For Ototopical Use In Dogs

Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian.

Federal law prohibits the extra label use of this drug in food-producing animals.

During clinical trials, dogs exhibited acute inflammation of the ear canal and pinna. In an animal safety study, erythema was noted. Baytril^® Otic is contraindicated in dogs with suspected or known hypersensitivity to quinolones and/or sulfonamides. The safe use of Baytril^® Otic in dogs used for breeding purposes, during pregnancy, or in lactating bitches, has not been evaluated. The use of Baytril^® Otic in dogs with perforated tympanic membranes has not been evaluated. Therefore, the integrity of the tympanic membrane should be evaluated before administering this product. If hearing or vestibular dysfunction is noted during the course of treatment, discontinue use of Baytril^® Otic. Quinolone-class drugs should be used with caution in animals with known or suspected Central Nervous System (CNS) disorders. In such animals, quinolones have, in rare instances, been associated with CNS stimulation which may lead to convulsive seizures. Quinolone-class drugs have been associated with cartilage erosions in weight bearing joints and other forms of arthropathy in immature animals of various species.

Product Label